Sites Menu > Medication Information - Other


Medication Information - Other


Nonprescription Analgesic Use: Precautions and New Concerns

US Pharm. 2008;33(5):18-21.

Clomid®

Clotting events appear to be rare with Clomid®, and it is not known whether they are coincidental or causatively related. There is, therefore, no clear indication for a patient like the one above to be on a blood thinner while taking Clomid®. Blood thinners may, actually, increase the risk of bleeding into the developing ovarian follicle and, thus, cause unwanted side effects. Weighing the risk and benefit it may be appropriate not to have this patient on blood thinners during Clomid® therapy, but only during pregnancy. Last Updated: 12/22/06

Safe Options for Home Needle Disposal


LYRICA

Prescribing Information

Progressive Multifocal Leukoencephalopathy (PML) in Two Lupus Patients Treated with Rituximab (Rituxan): An HSS Rheumatology Perspective

January 03, 2007

Rituximab in rheumatic diseases

Joint Bone Spine. Volume 74, Issue 1 , January 2007, Pages 4-6.

Nonprescription Analgesic Use: Precautions and New Concerns

US Pharm. 2008;33(5):18-21. W. Steven Pray, PhD, DPh, Bernhardt Professor of Nonprescription Drugs and Devices, College of Pharmacy, Southwestern Oklahoma State University, Weatherford, Oklahoma

Nitrostat Sublingual

WebMD Health

HYDROXYCHLOROQUINE (Plaquenil)

Updated Oct 2006. Written by Michael Cannon, MD, and reviewed by the American College of Rhematology Patient Education Task Force.

Persantin

This medicine contains the active ingredient dipyridamole, which is a type of medicine known as an antiplatelet agent. It prevents blood cells called platelets from clumping together inside the blood vessels, and is sometimes referred to as a 'blood thinner'. It also dilates the blood vessels.

Axert (Almotriptan Malate)

AXERT® (almotriptan malate) Tablets should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease. AXERT® should not be given to patients with hemiplegic or basilar migraine.

Thrombolytic Agents (Systemic)

Revised: 12/2003

Prednisone Oral

WebMD Health

Frova (Frovatriptan succinate)

Do not use FROVA if you have uncontrolled high blood pressure; have heart disease or a history of heart disease; have had a stroke; have circulation (blood flow) problems; or have hemiplegic or basilar migraine (if you are not sure about this, ask your doctor). If you're taking a selective serotonin reuptake inhibitor (SSRI) or another medication to treat depression, talk to your doctor before taking FROVA. Do not take FROVA if you have an allergic reaction to the tablet or within 24 hours of taking any triptans or ergotamine medications. The most common side effects associated with the use of FROVA are dizziness, tiredness, feeling of tingling, hot flashes, headache (other than migraine headache), dry mouth, hot or cold sensation, pain in joints or bones, chest pain, and indigestion.

Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia

CHEST, Feb, 2005 by John R. Bartholomew

Common Adverse Events and Interactions with OTC Pain Medications

US Pharm. 2008;33(5):44-56. CONCLUSION: OTC pain medications should be used at the lowest effective dose for the shortest duration possible to minimize the potential risk for an adverse event. Patients taking acetaminophen should not exceed the recommended maximum daily dose, while patients taking NSAIDs should not exceed the recommended single or daily dose. Doses given to children and infants should be very carefully measured, with the dosing device that comes packaged with the drug product. Labels for prescription medications containing OTC ingredients should be clear and should not contain abbreviations such as APAP. Patient and consumer education is also essential in preventing damage caused by these seemingly harmless medications. The pharmacist has a great opportunity to intervene. Encourage patients who take prescription medications containing acetaminophen or an NSAID to pay special attention to the ingredients on any OTC medication labels they are also using to reduce the incidence of accidental analgesic overdosing. Provide educational materials to patients so that they may learn to recognize the generic names of these medications. Warn consumers of the risks of misusing OTC pain relievers. While these drugs are safe and effective when taken at recommended doses, they may be quite harmful, even fatal, when taken inappropriately. Pharmacists can make a critically important contribution to the safety of patients taking acetaminophen- and NSAID-containing products. It is our duty to help patients use OTC medications safely.

The Way Eye See It...An Update on Antimalarial Eye Toxicity Monitoring

Written by: Gale A McCarty, MD, FACP, FACR. Bottom Line. Patients on anti-malarials should discuss these new recommendations with their rheumatologists and eye doctors, so that everyone is on the same page. Patients should be their own best advocates by discussing eye testing with their providers, as guidelines often evolve into accepted “standards of care” over time.

Progestin-only Contraceptives and Blood Clots

It is well known that combination contraceptives (containing estrogens AND progestins) increase the risk for blood clots (venous thromboembolism = VTE). Relatively few data, however, have been published on progestin-only contraceptives, so that until recently it has not been clear whether they increase the risk for VTE or not.

Progestin-only Contraceptives and Blood Clots

It is well known that combination contraceptives (containing estrogens AND progestins) increase the risk for blood clots (venous thromboembolism = VTE). Relatively few data, however, have been published on progestin-only contraceptives, so that until recently it has not been clear whether they increase the risk for VTE or not.

Tylenol use with Coumadin® (warfarin)

Overall, there have been very few reports of acetaminophen-associated effects on warfarin therapy. For decades, acetaminophen, the medicine in Tylenol, has been recognized as the over-the-counter pain reliever of choice for patients on warfarin therapy because TYLENOL®— unlike aspirin, naproxen sodium, ketoprofen, and even ibuprofen — does not cause gastrointestinal bleeding, nor does it inhibit the aggregation of platelets critical to normal blood clotting. It is very important that patients on warfarin have their blood clotting function monitored by their doctor and not change over-the-counter pain relievers without first consulting their doctors. If you are under a doctor's care for any serious condition or are taking any other drug, you should talk to your doctor if you want to know more or have other questions.

The Way Eye See It...An Update on Antimalarial Eye Toxicity Monitoring

Written by: Gale A McCarty, MD, FACP, FACR


Search our Sites

 

Previous [1] [2]



AUTOMATE your Links Pages with LinksManager.com!

 

 

The APS Foundation of America, Inc. website and forums are both volunteer run and funded by donations to the APSFA.

Website hosted by Dreamhost. Website created and maintained by Heidi P.

DISCLAIMER: APS Foundation of America, Inc. website is not intended to replace standard doctor-patient visits, physical examination, and medical testing. Information given to members is only an opinion. All information should be confirmed with your personal doctor. Always seek the advice of a trained physician in person before seeking any new treatment regarding your medical diagnosis or condition. Any information received from APS Foundation of America, Inc. website is not intended to diagnose, treat, or cure. This site is for informational purposes only. Please note that we will be listing all donor or purchaser's names on the Donor page of our foundation site. If you do not want your name listed, please contact us to opt out. If you think you may have a medical emergency, call your doctor or 911 immediately.

APS Foundation of America, Inc. will be building a database with your email, name and address information for future mailings. Your information will be kept confidential and not sold to any third parties. You may opt out at anytime by emailing us.

APSFA ©2005-2011 | APSFA Privacy Policy | APSFA Advertising Policy | 501(c)3 Public Charity EIN #203085295